Synthesis, biological evaluation and structure–activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides

European Journal of Medicinal Chemistry
2014.0

Abstract

Six series of 2-substituted 4-aminobutanamide derivatives were synthesized and evaluated for their ability to inhibit GABA transport proteins mGAT1-4 stably expressed in HEK-293 cell lines. The pIC50 values determined were in the range 4.23-5.23. Two compounds (15b and 15c) were selected for further in vitro studies. These compounds were also subjected to preliminary behavioral studies to evaluate their anticonvulsant, antidepressant-like, and antinociceptive activities in mice. Their influence on motor coordination was also assessed. We report that, among a spectrum of in vivo activities, both 15b and 15c displayed significant activity against pentylenetetrazole (PTZ)-induced seizures.

Knowledge Graph

Similar Paper

Synthesis, biological evaluation and structure–activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides
European Journal of Medicinal Chemistry 2014.0
Synthesis, characterization, and pharmacological evaluation of new GABA analogs as potent anticonvulsant agents
Medicinal Chemistry Research 2012.0
Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: A pharmacophoric hybrid approach
Bioorganic & Medicinal Chemistry Letters 2007.0
Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1–mGAT4: Synthesis and biological evaluation
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1–mGAT4
European Journal of Medicinal Chemistry 2008.0
Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors
European Journal of Medicinal Chemistry 2013.0
Azetidine derivatives as novel γ-aminobutyric acid uptake inhibitors: Synthesis, biological evaluation, and structure–activity relationship
European Journal of Medicinal Chemistry 2010.0
The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an anticonvulsant drug candidate
Journal of Medicinal Chemistry 1993.0
Synthesis of new piperidyl indanone derivatives as anticonvulsant agents
Medicinal Chemistry Research 2012.0
Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors
Bioorganic & Medicinal Chemistry 2013.0